Literature DB >> 32562665

Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19.

Yuqin Wu1, Zhicai Feng2, Peng Li1, Qizhi Yu3.   

Abstract

OBJECTIVE: To explore ABO blood group distribution and clinical characteristics in patients with COVID-19.
METHODS: The clinical data of 187 patients with COVID-19 seen between January 20, 2020 and March 5, 2020 at the First Hospital of Changsha were retrospectively analyzed. The differences in the ABO blood group distribution between COVID-19 patients and the control group (1991 cases) were analyzed. The relationship between blood type and clinical characteristics was analyzed.
RESULTS: Of the 187 patients with COVID-19, 69 had type A (36.90%), 63 had type B (33.69%), 41 had type O (21.92%), and 14 had type AB blood (7.49%). The proportion of patients with type A blood in the COVID-19 group was significantly higher than that in the control group (36.90% vs. 27.47%, P = 0.006), while the proportion of patients with type O blood in the COVID-19 group was significantly lower than that in the control group (21.92% vs. 30.19%, P = 0.018). The risk of COVID-19 was higher for individuals with blood group A than for those with blood group O (OR = 1.849, 95% CI = 1.228-2.768, P = 0.003). The risk of COVID-19 was higher for patients with blood group A than for those with a blood group other than A (OR = 1.544, 95% CI = 1.122-2.104, P = 0.006). Patients with blood group O had a lower risk of COVID-19 than non-O blood group patients (OR = 0.649, 95% CI = 0.457-0.927, P = 0.018). The ABO blood group distribution was related to COVID-19 status.
CONCLUSIONS: Patients with blood group A had an increased risk for infection with SARS-CoV-2, whereas blood group O was associated with a decreased risk, indicating that certain ABO blood groups were correlated with SARS-CoV-2 susceptibility. Blood type was related to some clinical characteristics of patients with COVID-19.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABO blood group; COVID-19; Clinical characteristics

Mesh:

Substances:

Year:  2020        PMID: 32562665     DOI: 10.1016/j.cca.2020.06.026

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  80 in total

Review 1.  ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Fabio Candura; Nadia Lopez; Ilaria Pati; Simonetta Pupella; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2021-05-12       Impact factor: 3.443

2.  Variation in COVID-19 Disease Severity and Clinical Outcomes Between Different ABO Blood Groups.

Authors:  Diyaa H Bokhary; Nidal H Bokhary; Lamees E Seadawi; Ahlam M Moafa; Hashim H Khairallah; Abdullah A Bakhsh
Journal:  Cureus       Date:  2022-02-02

3.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

4.  ABO in Correlation to the Requirement of Mechanical Ventilation and Mortality in Critically Ill Patients With COVID-19.

Authors:  Rehab Y Al-Ansari; Abdulaziz Alshaer; Aamer Al-Anazi; Nasser Al-Otaibi; Leena Abdalla; Sufana Al-Tarrah; Amal Shilash; Nada Al-Zahrani
Journal:  J Hematol       Date:  2021-04-27

Review 5.  COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.

Authors:  Jae C Chang
Journal:  Vasc Health Risk Manag       Date:  2021-06-01

Review 6.  Systematic review and meta-analysis of the susceptibility of ABO blood group to COVID-19 infection.

Authors:  Saeed M Kabrah; Ahmed M Kabrah; Arwa F Flemban; Samer Abuzerr
Journal:  Transfus Apher Sci       Date:  2021-05-21       Impact factor: 1.764

7.  ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients.

Authors:  David J Hermel; Samantha R Spierling Bagsic; Carrie L Costantini; James R Mason; Zhubin J Gahvari; Alan Saven
Journal:  Future Sci OA       Date:  2021-06-12

8.  Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2.

Authors:  Jean-Louis Bayart; Laure Morimont; Mélanie Closset; Grégoire Wieërs; Tatiana Roy; Vincent Gerin; Marc Elsen; Christine Eucher; Sandrine Van Eeckhoudt; Nathalie Ausselet; Clara David; François Mullier; Jean-Michel Dogné; Julien Favresse; Jonathan Douxfils
Journal:  Microorganisms       Date:  2021-06-21

9.  The Probable Association between Blood Groups and Prognosis of COVID-19.

Authors:  Maryam Nasiri; Javad Khodadadi; Zahra Hajrezaei; Negar Bizhani
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

10.  Association of blood groups on the risk of COVID-19 infection, morbidity, and mortality.

Authors:  Meltem Sertbas; Volkan Kizilay; Selma Dagci; Pinar Eker; Zeynep Yazici; Ebru Elci Solak; Serkan Elarslan; Nurettin Yiyit; Yasar Sertbas; Kamil Ozdil
Journal:  North Clin Istanb       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.